BMS-986202
BMS-986202 is a potent, selective and orally active Tyk2 inhibitor that binds to Tyk2 JH2 with an IC50 value of 0.19 nM and a Ki of 0.02 nM. BMS-986202 is remarkably selective over other kinases including Jak family members. BMS-986202 is also a weak inhibitor of CYP2C19 with an IC50 value of 14 μM. BMS-986202 can be used for IL-23-driven acanthosis, anti-CD40-induced colitis, and spontaneous lupus research. BMS-986202 is a de novo deuterium[1].
Product Specifications
CAS Number
[1771691-34-9]
UNSPSC
12352005
Target
Cytochrome P450; JAK
Type
Isotope-Labeled Compounds
Related Pathways
Epigenetics; JAK/STAT Signaling; Metabolic Enzyme/Protease; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Purity
99.29
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=C(NC1=NC=C(C(NC2=CC=CC(C3=NC=C(C=N3)F)=C2OC)=C1)C(NC([2H])([2H])[2H])=O)C4CC4
Molecular Formula
C22H18D3FN6O3
Molecular Weight
439.46
References & Citations
[1]Chunjian Liu, et al. Discovery of BMS-986202: A Clinical Tyk2 Inhibitor that Binds to Tyk2 JH2. J Med Chem. 2021 Jan 14;64 (1) :677-694.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
Phase 1
Isoform
CYP2; Tyk2
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
DNA-RNA Hybrid Monoclonal Antibody, AbBy Fluor™ 488 Conjugated
Lentiviral human RABL2A shRNA (UAS) - Lentiviral human RABL2A shRNA (UAS, RFP) (100)
